跳转至内容
Merck
CN
HomeWebinarsPAT Implementation for ADC & Bioconjugation Processes: Applications and Case Studies

PAT Implementation for ADC & Bioconjugation Processes: Applications and Case Studies



WEBINAR

With drug developers and manufacturers facing closer scrutiny on product quality than ever before, we as industry-leading CDMO are continuously evolving process analytical technology to design robust and cost-effective control strategies and understand more about the characteristics of your ADC or bioconjugate.  

In this webinar, we discuss the pros and cons of in(on)line testing for the conjugation process, highlight PATs at different steps, and share advancements through case studies for real-time monitoring of the reduction and conjugation process by online HPLC.

Speakers

Yiyi Li

Yiyi Li

Merck

R&D Scientist, ADC & LNP Template Innovation

Yiyi Li has been with Merck for 3 years. She is an R&D scientist in ADC & LNP Template Innovation group, focusing on analytical method development and optimization. Before she joined us, she worked in an analytical laboratory at the University of Missouri, Columbia, performing analytical testing by employing GC and HPLC-based methodologies. She earned her bachelor’s degree in biomedical engineering from East China University of Science and Technology, Shanghai. She earned her master’s degree in biomedical engineering from the University of Missouri, Columbia.

Mary Ramisetty

Mary Ramisetty

Merck

Senior Scientist Group Lead Process & Analytical Development

Mary Ramisetty is a senior scientist group lead at Merck. Her focus is on the process and analytical development of ADCs in support of GMP manufacturing. With more than 12 years of hands-on experience spanning analytical R&D, new product development, quality control, and manufacturing science and technology, she has a comprehensive understanding of the pharmaceutical landscape. She also holds certification as a project manager and is adept at leading project teams and facilitating commercial product launches.

登录以继续。

如要继续阅读,请登录或创建帐户。

暂无帐户?